Ownership

Martin Wilson

Insider Reports History

Entity: Individual
Location: C/O Teligent, Inc., 105 Lincoln Avenue, Buena, NJ
Signature: /s/ Martin Wilson
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Wilson:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
ROCKET PHARMACEUTICALS, INC.	General Counsel	Stock Option (Right to Buy)	135K	$2.03M	$15.04	Feb 11, 2025	Direct
ROCKET PHARMACEUTICALS, INC.	General Counsel	Common Stock	151K	$1.59M	$10.58	Feb 21, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Martin Wilson

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 21, 2025	1	-$34.1K	4	Feb 25, 2025	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 11, 2025	2	$0	4	Feb 13, 2025	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Nov 21, 2024	1	-$15.3K	4	Nov 25, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Aug 16, 2024	1	-$19K	4	Aug 20, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	May 14, 2024	7	-$24.5K	4	May 20, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 29, 2024	1	-$120K	4	Mar 4, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 16, 2024	3	-$107K	4	Feb 21, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 14, 2024	2	$0	4	Feb 16, 2024	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Feb 14, 2023	2	$0	4	Feb 16, 2023	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Aug 12, 2022	2	$0	4	Aug 16, 2022	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Dec 6, 2021	1	$0	4	Dec 8, 2021	General Counsel
RCKT	ROCKET PHARMACEUTICALS, INC.	Dec 6, 2021	0	$0	3	Dec 8, 2021	General Counsel